Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency
New coating technologies achieve high uniformity and reduce waste through mixing system advances and pan and airflow configuration.


Pharmaceutical Technology
Volume 36, Issue 6, pp. 44-46

As the pharmaceutical market continues to grow, tablet manufacturers face countless operational decisions that impact their ability to compete. Processing efficiency is one of the most important issues, affecting time-to-market, budgets, and product margins.

Advanced tablet-coating technologies increase manufacturing efficiency and help manufacturers produce more tablets in less time by improving coating uniformity, reducing coating solution waste, and minimizing cleaning and maintenance.

Improved uniformity


Figure 1: Patented, high-efficiency coating drum (L.B. Bohle).
The biggest limitation of traditional tablet coaters is the amount of time and solution required to achieve uniformity. Typically, for a cosmetic coating (i.e., instant-release coating) using a conventional coater, tablet weight must increase 4–5% to achieve a uniform coat. The newest drum coaters, however, achieve the same coverage with only a 1.5–2% weight gain, primarily due to an advanced mixing system and pan configuration.


Figure 2: (a) Unmixed tablets are (b) fully mixed after 10 min. in a high-efficiency coater (Bohle Tablet Coater, L.B. Bohle).
This improved uniformity and mixing effect results in better distribution of the coating solution on the tablet surface. Thus, with a lower weight gain, manufacturers are able to achieve the color specification required.

Mixing system


Table 1: Percentages of each tablet color in the front, middle, and back of the coating pan demonstrate complete mixing after 10 min.
The mixing system of a high-efficiency coater uses patented spiral baffles to move tablets constantly, as shown in Figure 1. One of the baffles moves tablets to the back of the pan while the other brings them forward. In 10 min or less, manufacturers can attain tablet homogeneity in each batch as was demonstrated in a mixing experiment with white, red, and green tablets (see Figure 2). In this experiment, an approximate 500 mL sample was taken from the front, middle, and back of the mixer after 2, 5, and 10 min, and the percentage of white, red, and green tablets in each location was calculated. As shown in Table I, the tablets in the middle were almost perfectly mixed after 2 min, and all zones were completely mixed after 10 min.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here